Palantir Technologies is experiencing explosive growth in its AI platform, yet its stock has taken a hit, falling 9%. Analysts are divided on its valuation, with some seeing it as overvalued despite record revenues. What does this mean for investors?
A major shareholder in Core Scientific is set to reject the proposed $5 billion acquisition by rival CoreWeave, raising doubts about one of 2023's largest data center mergers. Trip Miller of Gullane Capital argues the deal undervalues Core Scientific, while CoreWeave defends it as a strategic move. The upcoming vote on October 30 could reshape the future of both companies amidst growing investor concerns.
